Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ca-CIBLE
NCT05814341Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jul 2023
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Regiocit in acute kidney injury (AKI), sponsored by Assistance publique - Hôpitaux de Paris. Started Jul 2023; status: completed.
02
Drugs
Regiocit
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT05814341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05814341.